Takeda Pharmaceutical
313 hedge funds and large institutions have $1.09B invested in Takeda Pharmaceutical in 2024 Q1 according to their latest regulatory filings, with 40 funds opening new positions, 117 increasing their positions, 85 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
313
Holders Change
+7
Holders Change %
+2.29%
% of All Funds
4.54%
Holding in Top 10
1
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-80%
% of All Funds
0.01%
New
40
Increased
117
Reduced
85
Closed
30
Calls
$26.1M
Puts
$1.72M
Net Calls
+$24.4M
Net Calls Change
-$5.06M
Top Buyers
1 |
MIP
Mondrian Investment Partners
London,
United Kingdom
|
+$54.8M |
2 |
Bank of America
Charlotte,
North Carolina
|
+$9.02M |
3 |
![]()
Fidelity Investments
Boston,
Massachusetts
|
+$5.5M |
4 |
VanEck Associates
New York
|
+$5.01M |
5 |
SW
Simplicity Wealth
Summit,
New Jersey
|
+$4.01M |
Top Sellers
1 |
Morgan Stanley
New York
|
-$65.3M |
2 |
Millennium Management
New York
|
-$57.9M |
3 |
TAM
TFG Asset Management
Grand Cayman,
Cayman Islands
|
-$27.2M |
4 |
YDMI
Y.D. More Investments
Ramat Gan,
Israel
|
-$17M |
5 |
Capital Research Global Investors
Los Angeles,
California
|
-$16.3M |